Cytidine deaminase activity in synovial fluid of patients with rheumatoid arthritis: relation to lactoferrin, acidosis, and cartilage proteoglycan release. 1990

B Månsson, and P Geborek, and T Saxne, and S Björnsson
Department of Rheumatology, University Hospital of Lund, Sweden.

It is claimed that cytidine deaminase activity reflects local granulocyte turnover or activity in the synovial fluid of patients with rheumatoid arthritis, but cytidine deaminase is not a granulocyte specific enzyme. Lactoferrin is a granulocyte specific protein that is released from the secondary granulae during activation. We measured cytidine deaminase activity and lactoferrin concentrations in 33 rheumatic synovial fluid samples. Cytidine deaminase activity and lactoferrin concentrations correlated closely, indicating that both analyses reflect similar events in the joint-that is, result in their release from granulocytes. Cytidine deaminase activity and granulocyte concentrations correlated less closely, suggesting that there are additional factors besides the cell number which contribute to this release. Joint acidosis may be one such factor, as pH and cytidine deaminase activity correlated inversely. There was no association with synovial fluid proteoglycan concentrations, a marker of cartilage degradation.

UI MeSH Term Description Entries
D007719 Knee Joint A synovial hinge connection formed between the bones of the FEMUR; TIBIA; and PATELLA. Superior Tibiofibular Joint,Joint, Knee,Joint, Superior Tibiofibular,Knee Joints,Superior Tibiofibular Joints,Tibiofibular Joint, Superior
D007781 Lactoferrin An iron-binding protein that was originally characterized as a milk protein. It is widely distributed in secretory fluids and is found in the neutrophilic granules of LEUKOCYTES. The N-terminal part of lactoferrin possesses a serine protease which functions to inactivate the TYPE III SECRETION SYSTEM used by bacteria to export virulence proteins for host cell invasion. Lactotransferrin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009700 Nucleoside Deaminases Catalyze the hydrolysis of nucleosides with the elimination of ammonia. Deaminases, Nucleoside
D011509 Proteoglycans Glycoproteins which have a very high polysaccharide content. Proteoglycan,Proteoglycan Type H
D002358 Cartilage, Articular A protective layer of firm, flexible cartilage over the articulating ends of bones. It provides a smooth surface for joint movement, protecting the ends of long bones from wear at points of contact. Articular Cartilage,Articular Cartilages,Cartilages, Articular
D003564 Cytidine Deaminase An enzyme that catalyzes the deamination of cytidine, forming uridine. EC 3.5.4.5. Cytidine Aminohydrolase,Aminohydrolase, Cytidine,Deaminase, Cytidine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B Månsson, and P Geborek, and T Saxne, and S Björnsson
June 1988, Annals of the rheumatic diseases,
B Månsson, and P Geborek, and T Saxne, and S Björnsson
July 1985, Lancet (London, England),
B Månsson, and P Geborek, and T Saxne, and S Björnsson
December 1987, British medical journal (Clinical research ed.),
B Månsson, and P Geborek, and T Saxne, and S Björnsson
January 1989, Journal of pharmaceutical and biomedical analysis,
B Månsson, and P Geborek, and T Saxne, and S Björnsson
January 1972, Arthritis and rheumatism,
B Månsson, and P Geborek, and T Saxne, and S Björnsson
January 1968, Acta medica Polona,
B Månsson, and P Geborek, and T Saxne, and S Björnsson
January 2001, Annals of the rheumatic diseases,
B Månsson, and P Geborek, and T Saxne, and S Björnsson
September 1971, Das Deutsche Gesundheitswesen,
B Månsson, and P Geborek, and T Saxne, and S Björnsson
January 1983, Terapevticheskii arkhiv,
B Månsson, and P Geborek, and T Saxne, and S Björnsson
July 1995, The Journal of rheumatology,
Copied contents to your clipboard!